US Drug Approval A040730

Hydralazine Hydrochloride  Apr 21, 2009

1 approved drug product.
Hydralazine Hydrochloride
  • Ingredients: Hydralazine Hydrochloride;
  • Dosage form: injectable;
  • Route of administration: injection;
  • Strength: 20mg/ml;
  • Approval date: April 21, 2009;
  • Marketing status: prescription.

Parties

Applicants
Countries
US

JSON preview

Similar records

Title

Source:  FDA Last updated:  Jun 5, 2019

From the Orange Book, a publication of the U.S. Food and Drug Administration. This record may not reflect the most current and accurate biomedical/scientific data available from the FDA.